Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Cerebellum ; 17(4): 447-460, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29480507

ABSTRACT

Many fMRI studies have shown activity in the cerebellum after peripheral nociceptive stimulation. We investigated whether the areas in the cerebellum that were activated after nociceptive thumb stimulation were separate from those after nociceptive toe stimulation. In an additional experiment, we investigated the same for the anticipation of a nociceptive stimulation on the thumb or toe. For his purpose, we used fMRI after an electrical stimulation of the thumb and toe in 19 adult healthy volunteers. Following nociceptive stimulation, different areas were activated by stimulation on the thumb (lobule VI ipsilaterally and Crus II mainly contralaterally) and toe (lobules VIII-IX and IV-V bilaterally and lobule VI contralaterally), i.e., were somatotopically organized. Cerebellar areas innervated non-somatotopically by both toe and thumb stimulation were the posterior vermis and Crus I, bilaterally. In the anticipation experiment, similar results were found. However, here, the somatotopically activated areas were relatively small for thumb and negligible for toe stimulation, while the largest area was innervated non-somatotopically and consisted mainly of Crus I and lobule VI bilaterally. These findings indicate that nociceptive stimulation and anticipation of nociceptive stimulation are at least partly processed by the same areas in the cerebellum. This was confirmed by an additional conjunction analysis. Based on our findings, we hypothesize that input that is organized in a somatotopical manner reflects direct input from the spinal cord, while non-somatotopically activated parts of the cerebellum receive their information indirectly through cortical and subcortical connections, possibly involved in processing contextual emotional states, like the expectation of pain.


Subject(s)
Anticipation, Psychological/physiology , Cerebellum/physiopathology , Nociceptive Pain/physiopathology , Pain Perception/physiology , Adolescent , Adult , Brain Mapping , Cerebellum/diagnostic imaging , Electric Stimulation , Female , Humans , Magnetic Resonance Imaging , Male , Nociceptive Pain/diagnostic imaging , Thumb/physiopathology , Toes/physiopathology , Young Adult
2.
J Neurosurg ; 130(1): 184-196, 2018 02 09.
Article in English | MEDLINE | ID: mdl-29424651

ABSTRACT

OBJECTIVE Traumatic neuromas may develop after nerve injury at the proximal nerve stump, which can lead to neuropathic pain. These neuromas are often resistant to therapy, and excision of the neuroma frequently leads to recurrence. In this study, the authors present a novel surgical strategy to prevent neuroma formation based on the principle of centro-central anastomosis (CCA), but rather than directly connecting the nerve ends to an autograft, they created a loop using a 3D-printed polyethylene Y-shaped conduit with an autograft in the distal outlets. METHODS The 3D-printed Y-tube with autograft was investigated in a model of rat sciatic nerve transection in which the Y-tube was placed on the proximal sciatic nerve stump and a peroneal graft was placed between the distal outlets of the Y-tube to form a closed loop. This model was compared with a CCA model, in which a loop was created between the proximal tibial and peroneal nerves with a peroneal autograft. Additional control groups consisted of the closed Y-tube and the extended-arm Y-tube. Results were analyzed at 12 weeks of survival using nerve morphometry for the occurrence of neuroma formation and axonal regeneration in plastic semi-thin sections. RESULTS Among the different surgical groups, the Y-tube with interposed autograft was the only model that did not result in neuroma formation at 12 weeks of survival. In addition, a 13% reduction in the number of myelinated axons regenerating through the interposed autograft was observed in the Y-tube with autograft model. In the CCA model, the authors also observed a decrease of 17% in the number of myelinated axons, but neuroma formation was present in this model. The closed Y-tube resulted in minimal nerve regeneration inside the tube together with extensive neuroma formation before the entrance of the tube. The extended-arm Y-tube model clearly showed that the majority of the regenerating axons merged into the Y-tube arm, which was connected to the autograft, leaving the extended plastic arm almost empty. CONCLUSIONS This pilot study shows that our novel 3D-printed Y-tube model with interposed autograft prevents neuroma formation, making this a promising surgical tool for the management of traumatic neuromas.


Subject(s)
Neuroma/prevention & control , Peripheral Nerve Injuries/surgery , Peroneal Nerve/transplantation , Printing, Three-Dimensional , Sciatic Nerve/injuries , Tissue Transplantation/instrumentation , Animals , Disease Models, Animal , Female , Neuroma/etiology , Rats , Rats, Inbred Lew , Suture Techniques , Tissue Transplantation/methods
3.
Wound Repair Regen ; 26(1): 16-26, 2018 01.
Article in English | MEDLINE | ID: mdl-29453855

ABSTRACT

In this study, we investigated whether postburn itch in rats, after a full thickness burn, is correlated to the nervous reinnervation of the burn wound area. For this purpose, we determined scratching duration (expressed as second/hour) at 24 hours, 2, 4, 8, and 12 weeks postburn and combined this with immunohistochemistry for protein gene product 9.5 (PGP9.5) to identify all nerve fibers, calcitonin gene related peptide (CGRP) to identify peptidergic fibers, tyrosine hydroxylase (TH) for sympathetic fibers, and growth-associated protein 43 (GAP-43) for regrowing fibers. We found a modest, but highly significant, increase in scratching duration of all burn wound rats from 3 to 12 weeks postburn (maximally 63 ± 9.5 second/hour compared to sham 3.1 ± 1.4 second/hour at 9 weeks). At 24 hours postburn, all nerve fibers had disappeared from the burn area. Around 4 weeks postburn PGP 9.5- and CGRP-immunoreactive nerve fibers returned to control levels. TH- and GAP-43-IR nerve fibers, which we found to be almost completely colocalized, did not regrow. No correlation was found between scratching duration and nervous reinnervation of the skin. The present results suggest that in rat, like in human, burn wound healing will induce increased scratching, which is not correlated to the appearance of nervous reinnervation.


Subject(s)
Burns/pathology , Nerve Regeneration/physiology , Peripheral Nerves/physiology , Pruritus/etiology , Skin/innervation , Wound Healing/physiology , Animals , Behavior, Animal , Biopsy, Needle , Burns/complications , Disease Models, Animal , Fluorescent Antibody Technique , Immunohistochemistry , Male , Nerve Fibers/pathology , Netherlands , Pruritus/physiopathology , Random Allocation , Rats , Rats, Wistar , Sensitivity and Specificity , Skin/pathology
4.
J Invest Dermatol ; 135(8): 2049-2057, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25848979

ABSTRACT

Skin innervation is a dynamic process that may lead to changes in nerve fiber density during pathological conditions. We have investigated changes in epidermal nerve fiber density in three different rat models that selectively produce chronic itch (the dry skin model), or itch and inflammation (the dermatitis model), or chronic inflammation without itch (the CFA model). In the epidermis, we identified peptidergic fibers-that is, immunoreactive (IR) for calcitonin gene-related peptide or substance P­and non-peptidergic fibers­that is, IR for P2X3. The overall density of nerve fibers was determined using IR for the protein gene product 9.5. In all three models, the density of epidermal peptidergic nerve fibers increased up to five times when compared with a sham-treated control group. In contrast, the density of epidermal non-peptidergic fibers was not increased, except for a small but significant increase in the dry skin model. Chronic inflammation showed an increased density of peptidergic fibers without itch, indicating that increased nerve fiber density is not invariably associated with itch. The finding that different types of skin pathology induced differential changes in nerve fiber density may be used as a diagnostic tool in humans, through skin biopsies, to identify different types of pathology and to monitor the effect of therapies.


Subject(s)
Calcitonin Gene-Related Peptide/metabolism , Dermatitis/pathology , Inflammation/pathology , Nerve Fibers/pathology , Pruritus/pathology , Receptors, Purinergic P2X3/metabolism , Skin/innervation , Substance P/metabolism , Acetone/adverse effects , Animals , Biopsy , Dermatitis/etiology , Dinitrochlorobenzene/adverse effects , Disease Models, Animal , Freund's Adjuvant/adverse effects , Inflammation/chemically induced , Male , Nerve Fibers/metabolism , Pruritus/chemically induced , Rats , Rats, Wistar , Skin/pathology
5.
PLoS One ; 9(10): e109029, 2014.
Article in English | MEDLINE | ID: mdl-25279562

ABSTRACT

Nerve injury may cause neuropathic pain, which involves hyperexcitability of spinal dorsal horn neurons. The mechanisms of action of spinal cord stimulation (SCS), an established treatment for intractable neuropathic pain, are only partially understood. We used Autofluorescent Flavoprotein Imaging (AFI) to study changes in spinal dorsal horn metabolic activity. In the Seltzer model of nerve-injury induced pain, hypersensitivity was confirmed using the von Frey and hotplate test. 14 Days after nerve-injury, rats were anesthetized, a bipolar electrode was placed around the affected sciatic nerve and the spinal cord was exposed by a laminectomy at T13. AFI recordings were obtained in neuropathic rats and a control group of naïve rats following 10 seconds of electrical stimulation of the sciatic nerve at C-fiber strength, or following non-noxious palpation. Neuropathic rats were then treated with 30 minutes of SCS or sham stimulation and AFI recordings were obtained for up to 60 minutes after cessation of SCS/sham. Although AFI responses to noxious electrical stimulation were similar in neuropathic and naïve rats, only neuropathic rats demonstrated an AFI-response to palpation. Secondly, an immediate, short-lasting, but strong reduction in AFI intensity and area of excitation occurred following SCS, but not following sham stimulation. Our data confirm that AFI can be used to directly visualize changes in spinal metabolic activity following nerve injury and they imply that SCS acts through rapid modulation of nociceptive processing at the spinal level.


Subject(s)
Flavoproteins/metabolism , Neuralgia/metabolism , Neuralgia/therapy , Peripheral Nerve Injuries/metabolism , Spinal Cord Dorsal Horn/metabolism , Spinal Cord Stimulation , Animals , Male , Nerve Fibers, Unmyelinated/physiology , Neuralgia/etiology , Peripheral Nerve Injuries/complications , Rats , Rats, Sprague-Dawley , Rats, Wistar , Sciatic Nerve/injuries , Sciatic Nerve/physiology
6.
Brain Res ; 1543: 83-92, 2014 Jan 16.
Article in English | MEDLINE | ID: mdl-24231552

ABSTRACT

The endogenous opioid enkephalin is known to inhibit spinal nociceptive transmission. Here we investigated activation of spinal enkephalinergic neurons by determining the proportions of c-Fos expressing (activated) spinal neurons that were enkephalinergic after different acute and chronic peripheral nociceptive stimuli. The number of c-Fos-activated neurons in the dorsal horn was increased after hind paw injection of capsaicin, formalin or complete Freund's adjuvant (CFA, 1.5 hrs - 4 days). The numbers of these neurons that were enkephalinergic increased after paraformaldehyde, and at 20 hrs, but not 1.5 hrs or 4 days post-CFA as compared to saline. In the spared nerve injury (SNI) model of neuropathic pain, c-Fos expression was increased acutely (2 hrs) and chronically (2 weeks), and a greater number of these were enkephalinergic in the nerve-injured animals acutely compared to controls (sham-SNI). Combining all acute (=2 hrs) versus chronic (≥20 hrs) treatment groups, there was a significant decrease in the percentage of activated neurons that were enkephalinergic in superficial layers, but a significant increase in the deeper layers of the dorsal horn in the chronic treatment group. It is concluded that the overall percentage of c-Fos activated neurons that contained enkephalin was not significantly different between acute and chronic pain phases. However, the shift in localization of these neurons within the spinal dorsal horn indicates a noxious stimulus directed activation pattern.


Subject(s)
Enkephalins/metabolism , Neurons/metabolism , Pain/pathology , Protein Precursors/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Spinal Cord/pathology , Analysis of Variance , Animals , Capsaicin/toxicity , Disease Models, Animal , Enkephalins/genetics , Formaldehyde/toxicity , Freund's Adjuvant/toxicity , Hyperalgesia/physiopathology , Male , Neurons/drug effects , Pain/chemically induced , Pain Threshold/drug effects , Pain Threshold/physiology , Polymers/toxicity , Protein Precursors/genetics , Proto-Oncogene Proteins c-fos/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Time Factors
7.
PLoS One ; 7(4): e35293, 2012.
Article in English | MEDLINE | ID: mdl-22558137

ABSTRACT

The ventromedial medulla (VM), subdivided in a rostral (RVM) and a caudal (CVM) part, has a powerful influence on the spinal cord. In this study, we have identified the distribution of glycine and GABA containing neurons in the VM with projections to the cervical spinal cord, the lumbar dorsal horn, and the lumbar ventral horn. For this purpose, we have combined retrograde tracing using fluorescent microspheres with fluorescent in situ hybridization (FISH) for glycine transporter 2 (GlyT2) and GAD67 mRNAs to identify glycinergic and/or GABAergic (Gly/GABA) neurons. Since the results obtained with FISH for GlyT2, GAD67, or GlyT2 + GAD67 mRNAs were not significantly different, we concluded that glycine and GABA coexisted in the various projection neurons. After injections in the cervical cord, we found that 29% ± 1 (SEM) of the retrogradely labeled neurons in the VM were Gly/GABA (RVM: 43%; CVM: 21%). After lumbar dorsal horn injections 31% ± 3 of the VM neurons were Gly/GABA (RVM: 45%; CVM: 12%), and after lumbar ventral horn injections 25% ± 2 were Gly/GABA (RVM: 35%; CVM: 17%). In addition, we have identified a novel ascending Gly/GABA pathway originating from neurons in the area around the central canal (CC) throughout the spinal cord and projecting to the RVM, emphasizing the interaction between the ventromedial medulla and the spinal cord. The present study has now firmly established that GABA and glycine are present in many VM neurons that project to the spinal cord. These neurons strongly influence spinal processing, most notably the inhibition of nociceptive transmission.


Subject(s)
GABAergic Neurons/metabolism , Glycine/metabolism , Medulla Oblongata/cytology , Nociception/physiology , Spinal Cord/cytology , Animals , Fluorescence , Glutamate Decarboxylase/metabolism , Glycine Plasma Membrane Transport Proteins/metabolism , In Situ Hybridization, Fluorescence , Microspheres , Neural Pathways/physiology , Rats
8.
Neuroscientist ; 18(1): 8-14, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21362687

ABSTRACT

Nociceptive stimuli are transmitted through thinly myelinated or unmyelinated primary afferent fibers called nociceptors, which terminate mainly in the superficial dorsal horn of the spinal cord. While most nociceptive fibers terminate in the spinal segment of the entrance, (collateral) fibers may ascend and descend several segments upon their entry into the spinal cord, which is reflected in the receptive fields of central nociceptive neurons. In chronic pain states like inflammatory or neuropathic pain, the area of nociceptive activity may expand even further in rostrocaudal and mediolateral directions. Also, within minutes (inflammatory pain) or days (neuropathic pain), an increased sensitivity of peripheral and central nociceptive neurons will develop, which is referred to as sensitization. While anatomical, physiological, and psychophysical techniques have focused on one particular aspect of central sensitization at a time, functional imaging techniques like functional MRI, intrinsic optical imaging, and autofluorescent flavoprotein imaging (AFI) are able to capture both spatial and temporal dimensions of central sensitization simultaneously. AFI and other neuroimaging techniques may clarify fundamental aspects relating to the spread of nociceptive activity within the spinal cord and may thus provide a practical tool to test the efficacy of new analgesic drugs or procedures in animals and ultimately in humans.


Subject(s)
Central Nervous System Sensitization/physiology , Neuralgia/physiopathology , Neuroimaging , Nociceptors/physiology , Spinal Cord/physiopathology , Afferent Pathways/physiopathology , Animals , Chronic Pain/physiopathology , Neuroimaging/methods , Nociceptors/pathology , Pain/physiopathology , Rats , Spinal Cord/physiology , Synaptic Transmission/physiology
9.
J Neuropathol Exp Neurol ; 70(8): 662-77, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21760539

ABSTRACT

Motor neuron degeneration and skeletal muscle denervation are hallmarks of amyotrophic lateral sclerosis (ALS), but other neuron populations and glial cells are also involved in ALS pathogenesis. We examined changes in inhibitory interneurons in spinal cords of the ALS model low-copy Gurney G93A-SOD1 (G1del) mice and found reduced expression of markers of glycinergic and GABAergic neurons, that is, glycine transporter 2 (GlyT2) and glutamic acid decarboxylase (GAD65/67), specifically in the ventral horns of clinically affected mice. There was also loss of GlyT2 and GAD67 messenger RNA-labeled neurons in the intermediate zone. Ubiquitinated inclusions appeared in interneurons before 20 weeks of age, that is, after their development in motor neurons but before the onset of clinical signs and major motor neuron degeneration, which starts from 25 weeks of age. Because mutant superoxide dismutase 1 (SOD1) in glia might contribute to the pathogenesis, we also examined neuron-specific G93A-SOD1 mice; they also had loss of inhibitory interneuron markers in ventral horns and ubiquitinated interneuron inclusions. These data suggest that, in mutant SOD1-associated ALS, pathological changes may spread from motor neurons to interneuronsin a relatively early phase of the disease, independent of the presence of mutant SOD1 in glia. The degeneration of spinal inhibitory interneurons may in turn facilitate degeneration of motor neurons and contribute to disease progression.


Subject(s)
Amyotrophic Lateral Sclerosis , Interneurons/pathology , Motor Neurons/pathology , Nerve Degeneration/etiology , Neuroglia/metabolism , Spinal Cord/pathology , Activating Transcription Factor 3/metabolism , Age Factors , Amyotrophic Lateral Sclerosis/complications , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Animals , Calbindins , Choline O-Acetyltransferase/metabolism , Disease Models, Animal , Galectin 3/metabolism , Gene Expression Regulation/genetics , Glutamate Decarboxylase/genetics , Glutamate Decarboxylase/metabolism , Glycine Plasma Membrane Transport Proteins/genetics , Glycine Plasma Membrane Transport Proteins/metabolism , Green Fluorescent Proteins/genetics , Humans , Interneurons/metabolism , Mice , Mice, Transgenic , Motor Neurons/metabolism , Mutation/genetics , Parvalbumins/metabolism , Proto-Oncogene Proteins c-jun/metabolism , RNA, Messenger/metabolism , S100 Calcium Binding Protein G/metabolism , Superoxide Dismutase/genetics , Ubiquitin/metabolism
10.
Pain ; 151(2): 356-365, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20727678

ABSTRACT

The inhibitory transmitters GABA and glycine play an important role in modulating pain transmission, both in normal and in pathological situations. In the present study we have combined in situ hybridization for identifying spinal neurons that use the transmitter(s) glycine and/or GABA (Gly/GABA neurons) with immunohistochemistry for c-fos, a marker for neuronal activation. This procedure was used with acute pain models induced by the injection of capsaicin or formalin; and chronic pain models using Complete Freund's Adjuvant (CFA, chronic inflammation), and the spared nerve injury (SNI) model (neuropathic pain). In all models Gly/GABA neurons were activated as indicated by their expression of c-fos. The pattern of Gly/GABA neuronal activation was different for every model, both anatomically and quantitatively. However, the averaged percentage of activated neurons that were Gly/GABA in the chronic phase (≥20h survival, 46%) was significantly higher than in the acute phase (≤2h survival, 34%). In addition, the total numbers of activated Gly/GABA neurons were similar in both phases, showing that the activation of non-Gly/GABA (presumed excitatory) neurons in the chronic phase decreased. Finally, morphine application equally decreased the total number of activated neurons and activated Gly/GABA neurons. This showed that morphine did not specifically activate Gly/GABA neurons to achieve nociceptive inhibition. The present study shows an increased activity of Gly/GABA neurons in acute and chronic models. This mechanism, together with mechanisms that antagonize the effects of GABA and glycine at the receptor level, may determine the sensitivity of our pain system during health and disease.


Subject(s)
Gene Expression Regulation/physiology , Glycine/metabolism , Pain Threshold/physiology , Pain/pathology , Proto-Oncogene Proteins c-fos/metabolism , Sensory Receptor Cells/metabolism , Spinal Cord/pathology , gamma-Aminobutyric Acid/metabolism , Animals , Capsaicin/adverse effects , Cell Count/methods , Disease Models, Animal , Formaldehyde/adverse effects , Glutamate Decarboxylase/genetics , Glutamate Decarboxylase/metabolism , Glycine Plasma Membrane Transport Proteins/genetics , Glycine Plasma Membrane Transport Proteins/metabolism , Male , Pain/chemically induced , Pain/classification , Pain Threshold/drug effects , Proto-Oncogene Proteins c-fos/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar
11.
Mol Pain ; 6: 43, 2010 Jul 23.
Article in English | MEDLINE | ID: mdl-20653942

ABSTRACT

BACKGROUND: In pain processing, long term synaptic changes play an important role, especially during chronic pain. The immediate early gene Arc/Arg3.1 has been widely implicated in mediating long-term plasticity in telencephalic regions, such as the hippocampus and cortex. Accordingly, Arc/Arg3.1 knockout (KO) mice show a deficit in long-term memory consolidation. Here, we identify expression of Arc/Arg3.1 in the rat spinal cord using immunohistochemistry and in situ hybridization following pain stimuli. RESULTS: We found that Arc/Arg3.1 is not present in naïve or vehicle treated animals, and is de novo expressed in dorsal horn neurons after nociceptive stimulation. Expression of Arc/Arg3.1 was induced in an intensity dependent manner in neurons that were located in laminae I (14%) and II (85%) of the spinal dorsal horn. Intrathecal injection of brain derived neurotrophic factor (BDNF) also induced expression of Arc/Arg3.1. Furthermore, 90% of Arc/Arg3.1 expressing neurons also contained the activity marker c-Fos, which was expressed more abundantly. Preproenkephalin mRNA was found in the majority (68%) of the Arc/Arg3.1 expressing neurons, while NK-1 was found in only 19% and GAD67 mRNA in 3.6%. Finally, pain behavior in Arc/Arg3.1 KO mice was not significantly different from their wild type littermates after application of formalin or after induction of chronic inflammatory pain. CONCLUSIONS: We conclude that Arc/Arg3.1 is preferentially expressed in spinal enkephalinergic neurons after nociceptive stimulation. Therefore, our data suggest that Arc/Arg3.1 dependent long term synaptic changes in spinal pain transmission are a feature of anti-nociceptive, i.e. enkephalinergic, rather than pro-nociceptive neurons.


Subject(s)
Cytoskeletal Proteins/biosynthesis , Enkephalins/metabolism , Nerve Tissue Proteins/biosynthesis , Nociceptors/physiology , Pain/physiopathology , Posterior Horn Cells/physiopathology , Spinal Cord/physiology , Animals , Brain-Derived Neurotrophic Factor/pharmacology , Cytoskeletal Proteins/genetics , Electric Stimulation , Hot Temperature , Male , Mice , Mice, Knockout , Nerve Tissue Proteins/genetics , Nociceptors/drug effects , Nociceptors/metabolism , Pain/metabolism , Pain Threshold , Posterior Horn Cells/drug effects , Posterior Horn Cells/metabolism , Rats , Rats, Wistar , Spinal Cord/drug effects , Spinal Cord/metabolism , Synaptic Transmission
12.
J Neurosci ; 30(11): 4081-7, 2010 Mar 17.
Article in English | MEDLINE | ID: mdl-20237278

ABSTRACT

Pain arises from activation of peripheral nociceptors, and strong noxious stimuli may cause an increase in spinal excitability called central sensitization, which is likely involved in many pathological pain states. So far, it has not been achieved to simultaneously visualize in vivo both the temporal and spatial aspects of spinal activity, including central sensitization. Using autofluorescent flavoprotein imaging (AFI), an optical technique suitable for mapping activity in nervous tissue, we demonstrate a close temporal and spatial correlation of electrically evoked nociceptive input with the spinal AFI signal, representing spinal neuronal activity. The AFI signal increases linearly with stimulation intensity. Furthermore, we found that the AFI signal was much larger in intensity and size when the same electrical stimulation was applied after the induction of central sensitization by a subcutaneous capsaicin injection. Finally, innocuous palpation of the hindpaw did not evoke an AFI response in naive animals, but after capsaicin injection a strong response was obtained. This is the first report demonstrating simultaneously the temporal and spatial propagation of spinal nociceptive activity in vivo.


Subject(s)
Flavoproteins/analysis , Nociceptors/chemistry , Nociceptors/physiology , Pain Measurement/methods , Spinal Cord/chemistry , Animals , Electric Stimulation , Immunohistochemistry , Microscopy, Fluorescence/methods , Pain/diagnosis , Pain/physiopathology , Rats , Sciatic Nerve/physiology , Spinal Cord/physiology , Time Factors
13.
Proc Natl Acad Sci U S A ; 105(17): 6338-43, 2008 Apr 29.
Article in English | MEDLINE | ID: mdl-18430798

ABSTRACT

Although Hox gene expression has been linked to motoneuron identity, a role of these genes in development of the spinal sensory system remained undocumented. Hoxb genes are expressed at high levels in the dorsal horn of the spinal cord. Hoxb8 null mutants manifest a striking phenotype of excessive grooming and hairless lesions on the lower back. Applying local anesthesia underneath the hairless skin suppressed excessive grooming, indicating that this behavior depends on peripheral nerve activity. Functional ablation of mouse Hoxb8 also leads to attenuated response to nociceptive and thermal stimuli. Although spinal ganglia were normal, a lower postmitotic neural count was found in the dorsalmost laminae at lumbar levels around birth, leading to a smaller dorsal horn and a correspondingly narrowed projection field of nociceptive and thermoceptive afferents. The distribution of the dorsal neuronal cell types that we assayed, including neurons expressing the itch-specific gastrin-releasing peptide receptor, was disorganized in the lumbar region of the mutant. BrdU labeling experiments and gene-expression studies at stages around the birth of these neurons suggest that loss of Hoxb8 starts impairing development of the upper laminae of the lumbar spinal cord at approximately embryonic day (E)15.5. Because none of the neuronal markers used was unexpressed in the adult dorsal horn, absence of Hoxb8 does not impair neuronal differentiation. The data therefore suggest that a lower number of neurons in the upper spinal laminae and neuronal disorganization in the dorsal horn underlie the sensory defects including the excessive grooming of the Hoxb8 mutant.


Subject(s)
Homeodomain Proteins/metabolism , Sensation , Spinal Cord/metabolism , Afferent Pathways/drug effects , Anesthetics, Local/pharmacology , Animals , Avoidance Learning/drug effects , Capsaicin/pharmacology , Embryo, Mammalian/drug effects , Embryo, Mammalian/pathology , Ganglia, Spinal/drug effects , Grooming/drug effects , Heterozygote , Homeodomain Proteins/genetics , Homozygote , Hot Temperature , Mice , Mice, Inbred C57BL , Mutation/genetics , Neurons/drug effects , Neurons/metabolism , Phenotype , Sensation/drug effects , Skin/drug effects , Skin/pathology , Spinal Cord/drug effects , Spinal Cord/embryology , Spinal Cord/pathology , beta-Galactosidase/metabolism
14.
Brain Res ; 1142: 61-9, 2007 Apr 20.
Article in English | MEDLINE | ID: mdl-17336274

ABSTRACT

Glycine transporter 2 (GlyT2) mRNA is exclusively expressed in glycinergic neurons, and is presently considered a reliable marker for glycinergic neuronal somata. In this study, we have performed non-radioactive in situ hybridization to localize GlyT2 mRNA in fixed free-floating sections of cervical (C2 and C6), thoracic (T5), lumbar (L2 and L5) and sacral (S1) segments of the rat spinal cord. The results showed that in all segments the majority of the GlyT2 mRNA labeled (glycinergic) neuronal somata was present in the deep dorsal horn and the intermediate zone (laminae III-VIII), with around 50% (range 43.7-70.9%) in laminae VII&VIII. In contrast, the superficial dorsal horn, the motoneuronal cell groups and the area around the central canal contained only few glycinergic neuronal somata. The density (number of glycinergic neuronal somata per mm(2)) was also low in these areas, while the highest densities were found in laminae V to VIII. The lateral spinal nucleus and the lateral cervical nucleus also contained a limited number of glycinergic neurons. Our findings showed that the distribution pattern of the glycinergic neuronal somata is similar in all the examined segments. The few differences that were found in the relative laminar distribution between some of the segments, are most likely due to technical reasons. We therefore conclude that the observed distribution pattern of glycinergic neuronal somata is present throughout the spinal cord. Our findings further showed that the non-radioactive in situ hybridization technique for identifying GlyT2 mRNA in fixed free-floating sections is a highly efficient tool for identifying glycinergic neurons in the spinal cord.


Subject(s)
Glycine/metabolism , Neurons/metabolism , Spinal Cord/cytology , Animals , Glycine Plasma Membrane Transport Proteins/genetics , Glycine Plasma Membrane Transport Proteins/metabolism , In Situ Hybridization/methods , Male , Neurons/cytology , RNA, Messenger/metabolism , Rats , Rats, Wistar
15.
J Comp Neurol ; 500(6): 1136-53, 2007 Feb 20.
Article in English | MEDLINE | ID: mdl-17183535

ABSTRACT

RET (for "rearranged during transfection") is a transmembrane tyrosine kinase signaling receptor for members of the glial cell line-derived neurotrophic factor (GDNF) family of ligands. We used RET immunohistochemistry (IHC), double-labeling immunofluorescence (IF), and in situ hybridization (ISH) in adult naïve and nerve-injured rats to study the distribution of RET in the spinal cord. In the dorsal horn, strong RET-immunoreactive (-ir) fibers were abundant in lamina II-inner (II(i)), although this labeling was preferentially observed after an antigen-unmasking procedure. After dorsal rhizotomy, RET-ir fibers in lamina II(i) completely disappeared from the dorsal horn, indicating that they were all primary afferents. After peripheral axotomy, RET-ir in primary afferents decreased in lamina II(i) and appeared to increase slightly in laminae III and IV. RET-ir was also observed in neurons and dendrites throughout the dorsal horn. Some RET-ir neurons in lamina I had the morphological appearance of nociceptive projection neurons, which was confirmed by the finding that 53% of RET-ir neurons in lamina I colocalized with neurokinin-1. GDNF-ir terminals were in close proximity to RET-ir neurons in the superficial dorsal horn. In the ventral horn, RET-ir was strongly expressed by motoneurons, with the strongest staining in small, presumably gamma-motoneurons. Increased RET expression following peripheral axotomy was most pronounced in alpha-motoneurons. The expression and regulation pattern of RET in the spinal cord are in line with its involvement in regenerative processes following nerve injury. The presence of RET in dorsal horn neurons, including nociceptive projection neurons, suggests that RET also has a role in signal transduction at the spinal level. This role may include mediating the effects of GDNF released from nociceptive afferent fibers.


Subject(s)
Motor Neurons/enzymology , Nerve Fibers/enzymology , Posterior Horn Cells/metabolism , Proto-Oncogene Proteins c-ret/metabolism , Animals , Axotomy , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Immunohistochemistry , Male , Nerve Degeneration/enzymology , Pain/enzymology , Protein-Tyrosine Kinases/metabolism , Rats , Rats, Wistar , Rhizotomy , Signal Transduction/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...